AU Patent

AU2013201243A1 — Bicyclic heteroaryl compounds

Assigned to Ariad Pharmaceuticals Inc · Expires 2013-03-28 · 13y expired

What this patent protects

H:\SXD\Interwoven\NRPortbl\DCC\SXD\4967550-1.DOC-4/03/2013 This invention relates to compounds of the general formula (1) in which the variable groups are as defined herein, and to their preparation and use. JL% TB

USPTO Abstract

H:\SXD\Interwoven\NRPortbl\DCC\SXD\4967550-1.DOC-4/03/2013 This invention relates to compounds of the general formula (1) in which the variable groups are as defined herein, and to their preparation and use. JL% TB

Drugs covered by this patent

ponatinib-hydrochloride (PONATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: AU2013201243A1
Jurisdiction: AU
Classification: —
Expires: 2013-03-28
Drug substance claim: No
Drug product claim: No
Assignee: Ariad Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.